richia coli (EPEC), a food-borne human pathogen, is responsible for infantile diarrhea, especially in developing countries. The pathophysiology of EPEC-induced diarrhea, however, is not completely understood. Our recent studies showed modulation of Na ϩ /H ϩ and Cl Ϫ / HCO 3 Ϫ exchange activities in Caco-2 cells in response to EPEC infection. We hypothesized that intestinal short-chain fatty acid absorption mediated by monocarboxylate transporter 1 (MCT1) might also be altered by EPEC infection. The aim of the current studies was to examine the effect of EPEC infection on butyrate uptake. Caco-2 cells were infected with wild-type EPEC, various mutant strains, or nonpathogenic E. coli HS4, and [
Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level short-chain fatty acids; ion transport; diarrhea; monocarboxylate transporter 1 BUTYRATE AND OTHER SHORT-CHAIN fatty acids (SCFAs) are produced by enteric bacterial fermentation of undigested carbohydrates and dietary fiber. SCFAs are avidly absorbed in the colon and serve as preferential fuel for colonic epithelial cells. Butyrate is the most important SCFA in colonocyte metabolism and is used preferentially over propionate and acetate. We have previously shown (12) that SCFA absorption across the epithelial membranes of the human ileum and colon involves an SCFA/HCO 3 Ϫ (OH Ϫ ) exchange mechanism. We and others also demonstrated the involvement of monocarboxylate transporter 1 (MCT1) in the luminal absorption of SCFAs in human intestinal epithelial cells (11, 28) . Butyrate is known to stimulate water and NaCl absorption via activation of Na ϩ /H ϩ exchanger (NHE; see Refs. 6 and 25) and apical Cl Ϫ /HCO 3 Ϫ exchangers (24) . The anti-inflammatory actions of butyrate are supported by both clinical and animal studies, implicating its role in suppressing mucosal inflammation (16) . Also, butyratecontaining retention enemas have proven beneficial in the treatment of ulcerative and diversion colitis (6) . Although decreased SCFA production resulting from impaired colonic fermentation has been shown to impair colonic absorption of sodium and water, little information is available on the factors that might influence efficient absorption of SCFAs by colonocytes. Particularly, no information is available on the modulation of SCFA uptake by pathogenic microorganisms that cause secretory and inflammatory diarrhea in humans. Enteropathogenic Escherichia coli (EPEC) is an important noninvasive human enteric pathogen associated with diarrhea, particularly in infants. Its infection causes specific histopathological alterations of the intestinal enterocytes, called attaching and effacing (A/E) lesions, characterized by effacement of microvilli, close adherence of the bacteria to the host cell membrane, and recruitment of filamentous actin and other cytoskeletal proteins resulting in pedestal formation beneath the sites of attachment (32) . The gene products required for producing A/E lesions are encoded by an ϳ35-kb pathogenicity island in the bacterial chromosome, known as the Locus of Enterocyte Effacement (LEE). The LEE encodes a number of virulence genes, including the components of a type III secretion system (TTSS) that allows direct transfer of bacterial effector molecules into host cells (22) . Several effectors, which are translocated into host cells via the TTSS, have been identified and characterized (21) . These include Tir, EspF, EspG, EspH, and Map. The complete mechanism(s) of EPECinduced diarrhea is not fully understood and appears to be multifactorial. One such factor may be impairment of ion and solute transport. Diarrhea associated with infection by enteric pathogens could result from either increased Cl Ϫ secretion, decreased NaCl absorption, or both. We have previously shown that Cl Ϫ /OH Ϫ exchange activity is inhibited in response to EPEC infection in Caco-2 cells (13) . Also, EPEC infection increased the activity of NHE2, whereas the activity of NHE3, the predominant Na ϩ -absorbing isoform, was inhibited (14) . Based on the fact that EPEC-induced diarrhea is multifactorial, and that SCFAs maintain mucosal integrity and influence water and electrolyte absorption, it was of interest to determine if butyrate absorption by mucosal cells is affected by EPEC infection. We report here that butyrate uptake by intestinal epithelial Caco-2 cells is significantly decreased by EPEC infection. We further show that membrane expression of MCT1, the SCFA transporter in the intestinal epithelial cells, is also decreased in response to EPEC infection.
MATERIALS AND METHODS

Materials. [
14 C]sodium butyrate was obtained from NEN Life Science Products (Boston, MA). Caco-2 cells were obtained from ATCC (American Type Culture Collection, Manassas, VA). Sulfo-NHS-SS-biotin for biotinylation of cell surface proteins and streptavidin agarose were from Pierce (Rockford, IL). All other reagents were of at least reagent grade and were obtained from Sigma (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).
Cell culture. Caco-2 cells were grown at 37°C in an atmosphere of 5% CO 2. Cells were maintained in DMEM with 4.5 g/l glucose, 50 U/ml penicillin, 5 g/ml streptomycin, 2 g/ml gentamicin, and 20% FBS. Cells used for these studies were plated on 24-well plates at a density of 2 ϫ 10 4 cells/well. Cells were used for bacterial infection and butyrate uptake on day 12-14 postplating and were grown overnight in a medium free of serum and antibiotic before infection.
Bacterial (8) and the nonpathogenic isolate HS4 (obtained from J. B. Kaper's laboratory). Strains were grown overnight in Milleva Luria Borth (LB) media. On the day of experiment, an aliquot of the overnight culture was inoculated in an appropriate volume of serum and antibiotic-free medium supplemented with 0.5% mannose. Bacteria were grown to midlog phase (optical density at 600 nm ϭ 0.4). The culture was spun down and resuspended in the same volume of fresh media. Cell monolayers were then infected at a multiplicity of infection of 100. After infection for the desired time, media were removed, and cell monolayers were washed with PBS. (1) with minor modifications. Briefly, EPEC-infected or control cell monolayers were washed three times with PBS containing 0.1 mM CaCl 2 and 1 mM MgCl2 at 4°C. The apical surface was then exposed to Sulfo-NHS-SS-biotin (Pierce) at a concentration of 1.5 mg/ml in borate buffer, pH 9.0, by incubation for 1 h at 4°C in horizontal motion. Cells were then quenched with PBS containing CaCl 2, MgCl2, and 100 mM glycine for 20 min at 4°C. Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris ⅐ Cl, pH 7.4, 5 mM EDTA, 1% Triton X-100, 0.1% SDS, and protease inhibitor cocktail). After centrifugation, the supernatant was incubated overnight in streptavidin agarose and then washed three times with lysis buffer. The streptavidin agarose beads were spun down, and sample loading buffer for SDS-PAGE was added. Separated proteins were probed with anti-MCT1 antibody and visualized with enhanced chemiluminescence reagent.
Statistical analysis. Results are expressed as means Ϯ SE. Each independent set of results represents data from at least six wells used in three to five separate experiments.
RESULTS
EPEC infection inhibits butyrate uptake in Caco-2 cells.
To determine whether EPEC infection had any effect on butyrate uptake, Caco-2 cells were infected for 1 h, and butyrate uptake was determined as pH-driven [
14 C]butyrate uptake, as described in MATERIALS AND METHODS. Figure 1 shows that butyrate uptake was decreased significantly (ϳ60%) in EPEC-infected cells compared with uninfected controls. In contrast, infection with nonpathogenic E. coli had no significant effect.
Time course of EPEC inhibition of butyrate uptake. The time course of EPEC-mediated inhibition of butyrate uptake was determined by infecting Caco-2 monolayers with EPEC for 15, 30, 60, 90, and 120 min. As shown in Fig. 2 points of infection (15 and 30 min), butyrate uptake was not significantly decreased, whereas ϳ70% inhibition of butyrate uptake occurred by 60 min postinfection and persisted for at least 120 min. Therefore, all subsequent experiments were performed at 60 min postinfection.
EPEC infection decreases the maximal velocity of butyrate uptake without altering the Michaelis constant. The kinetics of butyrate uptake by EPEC-infected and uninfected Caco-2 cells were measured using increasing substrate concentrations in the range of 0.5-15 mM. As shown in Fig. 3 , EPEC infection significantly decreased the activity of butyrate uptake at all concentrations examined. An analysis of the LineweaverBurke plot of this data showed that maximal velocity (V max ) of butyrate uptake in EPEC-infected cells compared with uninfected controls was reduced significantly (V max : in nmol⅐mg protein Ϫ1 ⅐5 min Ϫ1 : 15.9 Ϯ 0.1 for control vs. 9.1 Ϯ 0.1 in response to EPEC infection). In contrast, the apparent Michaelis constant (K m ) did not change significantly (control 2.52 Ϯ 0.04 mM vs. EPEC infected 2.71 Ϯ 0.02 mM ).
TTSS is required to inhibit butyrate uptake. The role of various EPEC virulence proteins on the EPEC-induced decrease in butyrate uptake by Caco-2 cells was investigated using specific mutant strains. First, involvement of the TTSS was studied using an escN mutant strain. The product of this gene is the putative ATPase that drives type III secretion of various virulence proteins (9) . As shown in Fig. 4 , there was no inhibition of butyrate uptake by Caco-2 cells when infected with the escN mutant strain, in contrast to significant inhibition by wild-type EPEC. These results reveal that a functional TTSS is required for EPEC to inhibit butyrate uptake by Caco-2 cells.
EPEC secreted proteins are involved in modulating butyrate uptake. We further analyzed the role of the TTSS in EPECmodulated butyrate uptake by infecting cells with either espA, espB, or espD mutant strains. Each of these virulence genes encodes a structural component of the TTSS; therefore, mutation of any one of them renders TTSS ineffective (22) . Figure  5 shows that infection of cells with these mutants had no effect on butyrate uptake compared with uninfected controls. Infection with wild-type EPEC, as expected, resulted in a marked decline in butyrate uptake. These results indicate that the structural components of the translocation apparatus themselves or the secreted effector molecules are required for the observed effect of EPEC on butyrate uptake.
Effector proteins EspF, EspG, EspH, and Map are not involved. EPEC infection results in the delivery of a number of effector proteins in the host cytosol. The role of these effector molecules in modulating butyrate uptake was also studied. Figure 6 shows that mutation of espF, -G, and -H, map, or of a double mutation of espG and its homolog orf3 had no impact on the inhibition of butyrate uptake caused by wild-type EPEC. These results suggest that these effector proteins are not involved in EPEC's effect on butyrate uptake.
Membrane expression of MCT1 is decreased by EPEC infection.
It has been previously shown by us and others (11, 28) that MCT1 is involved in the uptake of butyrate by Caco-2 cells. Therefore, to examine the effect of EPEC infection on MCT1 protein, cell surface proteins from control and infected cells were biotinylated and pulled down from the cell lysate by avidin, and separated proteins were probed with an anti-MCT1 antibody. As shown in Fig. 7A , surface expression of MCT1 in infected cells was decreased considerably compared with uninfected controls or those infected with nonpathogenic E. coli (HS4), whereas levels of total cellular MCT1 remained constant in all groups. Densitometric scanning of the band inten- sities revealed a Ͼ50% decrease in the amount of surface MCT1 compared with total MCT1 in EPEC-infected cells (Fig. 7B ).
DISCUSSION
Absorption of SCFAs is important for colonocyte health and metabolism, epithelial integrity, as well as colonic fluid and electrolyte balance. Butyrate, a key SCFA, is known to have multiple regulatory roles in the mammalian colon, including stimulation of fluid and electrolyte absorption (24) by increasing electroneutral NaCl absorption (3) and inhibiting Cl Ϫ secretion (27) . Recent studies (19) have also demonstrated that butyrate stimulates promoter activity and expression of the apical NHE3 in the human adenocarcinoma cell line Caco-2. Butyrate has also been implicated in suppressing mucosal inflammation (16) . Decreased production or availability of butyrate has been shown to result in chronic inflammation and acute diarrhea (6) . However, to date, the effects of enteric pathogens on the absorption of SCFAs have not been examined. EPEC is a human enteric pathogen infecting primarily infants and young children. The specific mechanisms by which EPEC causes early diarrhea in infected hosts, however, remain unclear. Diarrhea results from either increased secretion, impaired absorption, or both. EPEC infection has intact been shown to decrease secretagogue-induced Cl Ϫ secretion (15) . We have also shown that EPEC infection increases NHE2 activity, whereas the activity of NHE3, the predominant Na ϩ -absorbing isoform, is inhibited (14) . Cl Ϫ /OH Ϫ exchange activity was also shown to be inhibited in Caco-2 cells infected with EPEC (13) . We have also reported that EPEC infection induces inflammation (29) and disrupts the structure and barrier function of tight junctions after prolonged infections (26) . These findings suggest that the mechanism(s) of EPEC-induced diarrhea are multifactorial and may also involve modulation of SCFA uptake. Caco-2 cell monolayers were selected to investigate this question, since previous studies from our laboratory (11) demonstrated that this cell line was a suitable in vitro model to study butyrate uptake. The data presented here suggest that EPEC infection of confluent differentiated Caco-2 monolayers results in a significant decrease in butyrate uptake. This effect was specific, since infection with nonpathogenic E. coli (HS4) had no effect on butyrate uptake. Time course studies of EPEC inhibition of butyrate uptake showed effective inhibition as early as 60 min postinfection that persisted until 120 min.
EPEC is noninvasive and does not produce toxins. Instead, it employs the TTSS to deliver virulence factors directly in the host cells (32) . Several mutational studies have enabled identification of individual components of the TTSS. Requirement of an intact TTSS for EPEC to inhibit butyrate uptake is supported by the fact that mutation of the putative ATPase (EscN) blocked the inhibitory effect of EPEC infection. This mutant has also been shown to be ineffective in modulating Na ϩ (14) and Cl Ϫ (10) uptake by Caco-2 cells. Mutant strains carrying mutations in espA, espB, or espD, all of which interfere with type III secretion, also failed to inhibit butyrate uptake in infected Caco-2 cells. EspA forms a filamentous organelle on the bacterial surface that is postulated to act as a channel for the type III system to deliver proteins to the host cell (9) . EspB and EspD are translocated to the host cell membrane and together are thought to form the translocation pore. EspB also has been reported to be present in the cytoplasm; however, its function here is not known (9) .
The EPEC-secreted effector molecules have previously been reported to alter host cell functions via different mechanisms. For example, EspF is known to disrupt tight junctions (23); EspG, and its homolog Orf3, both disrupt microtubules and produce subtle alterations in barrier functions (8, 30) ; EspH is known to alter pedestal morphology and filopodia formation (31) , whereas Map has been reported to alter mitochondrial membrane potential (18) . However, our current studies suggested that the secreted effector molecules EspF, EspG, EspH, and Map were not involved in mediating the observed decrease Fig. 7 . A: surface expression of monocarboxylate transporter 1 (MCT1) is reduced in response to EPEC infection. Caco-2 cells were infected with EPEC or nonpathogenic E. coli (HS4) for 60 min. Cell surface proteins were biotinylated as described in MATERIALS AND METHODS. Biotinylated proteins were pulled down from equal aliquots of cell lysates (protein contents normalized to 2.5 mg/ml) using equal amounts of streptavidin agarose. SDS-PAGE of the biotinylated proteins or the total proteins in cell lysates were probed with anti-MCT1 antibody. The blot is representative of 3 separate experiments. B: densitometric scanning of the relative band intensities and ratio of surface MCT1 to total MCT1. Values are means Ϯ SE of 3 separate experiments. *P Ͻ 0.05 compared with control. Fig. 6 in butyrate uptake in response to EPEC infection, since these mutants behaved similar to wild-type EPEC in inhibiting butyrate uptake. Orf3, the espG homolog, is encoded in the EPEC genome in a locus distinct from the LEE. Because both effectors (EspG and Orf3) are known to induce disruption of microtubule networks beneath adherent bacteria (21), we used a double mutant of espG/orf3 to infect cells and observe the effects on butyrate uptake. There was again a significant inhibition of butyrate uptake, similar to that caused by wildtype EPEC, suggesting that these effector molecules are not involved in EPEC-mediated inhibition of butyrate uptake. However, the inability of nonpathogenic E. coli or type III secretion mutants to inhibit butyrate uptake seems to indicate that the observed effects are related to pathogenicity.
Our kinetic studies suggested that EPEC inhibited butyrate uptake via changes in the value of V max without significantly altering the apparent K m , indicating a decrease in the expression of the butyrate transporter on the plasma membrane. This was indeed found to be the case by performing biotinylation studies to quantitate the amount of surface MCT1, the butyrate transporter in Caco-2 cells. Although the surface expression of MCT1 was considerably lower in cells infected with EPEC compared with nonpathogenic E. coli, or uninfected control cells, total cellular MCT1 was the same in all the groups. These studies demonstrate the regulation of butyrate uptake either by retrieval of MCT1 from the apical plasma membrane or via reduced targeting to the apical membrane in response to EPEC infection. In this regard, previous studies of Buyse et. al. (5) also suggested that MCT1 is regulated by luminal leptin by altering translocation of MCT1 to the apical plasma membrane.
The effects of pathogenic organisms on fluid and electrolyte secretion by host intestinal epithelial cells have been well documented. Various enteric pathogens elicit a Cl Ϫ secretory response. The studies from our laboratory showed profound early effects of EPEC infection on intestinal epithelial absorption, an aspect that has not been studied previously. The observed effects of EPEC infection on butyrate uptake reported here and previously published results from our laboratory on Na ϩ /H ϩ and Cl Ϫ /OH Ϫ exchange activities strongly suggest that EPEC infection has profound effects on the host intestinal absorptive ion transport processes. We speculate that decreased butyrate availability caused by EPEC infection might compromise colonic epithelial integrity, resulting in inflammation of the epithelium, and also might contribute to EPEC-mediated diarrhea by inhibiting ion absorption in the colon. Our results demonstrate that EPEC requires a TTSS to inhibit butyrate uptake via regulation of MCT1. In lieu of the important role of SCFA in stimulating human colonic electrolyte absorption and being the key nutrient in the colon, our studies not only add to increased understanding of the mechanisms regulating human intestinal SCFA absorption but also suggest the potential role of inhibition of this key ion as an important contributory factor in the pathophysiology of EPEC-associated diarrhea.
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